Go Pro
OTCMKTS:BVNRY

Bavarian Nordic (BVNRY) Stock Price, News & Analysis

Bavarian Nordic logo
$10.69 +0.09 (+0.80%)
As of 09/21/2026 03:14 PM Eastern

About Bavarian Nordic Stock (OTCMKTS:BVNRY)

Advanced

Key Stats

Today's Range
$10.69
$10.72
50-Day Range
$8.76
$11.44
52-Week Range
$8.67
$13.00
Volume
3,075 shs
Average Volume
1,638 shs
Market Capitalization
$2.54 billion
P/E Ratio
10.80
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bavarian Nordic A/S (OTCMKTS:BVNRY) is a Danish biotechnology company that develops, manufactures and commercializes vaccines for infectious diseases. The company serves government agencies, military organizations, healthcare providers and travelers, with products distributed across Europe, North America and other international markets.

Its best-known product is JYNNEOS, also marketed as IMVAMUNE or IMVANEX in certain regions, a non-replicating smallpox and mpox vaccine. Bavarian Nordic also offers vaccines for rabies and tick-borne encephalitis, including RabAvert and Rabipur for rabies prevention and Encepur for protection against tick-borne encephalitis. Its portfolio includes vaccines used in routine, travel and outbreak-response settings.

Founded in 1994 and headquartered in Hellerup, Denmark, Bavarian Nordic has developed specialized vaccine production capabilities and works with public-sector customers on preparedness for infectious disease threats. The company also conducts research and development aimed at expanding its vaccine portfolio and addressing additional unmet needs in infectious disease prevention.

AI Generated. May Contain Errors.

Receive BVNRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bavarian Nordic and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BVNRY Stock News Headlines

Bavarian Nordic (OTCMKTS:BVNRY) Short Interest Update
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery.tc pixel
Bavarian Nordic AS ADR BVNRY
Bavarian Nordic A/S
See More Headlines

BVNRY Stock Analysis - Frequently Asked Questions

Bavarian Nordic's stock was trading at $9.9260 at the beginning of 2026. Since then, BVNRY stock has increased by 7.7% and is now trading at $10.69.

Bavarian Nordic (OTCMKTS:BVNRY) announced its quarterly earnings data on Friday, August, 21st. The company reported $0.46 earnings per share for the quarter. The business had revenue of $316.47 million for the quarter. Bavarian Nordic had a net margin of 24.36% and a trailing twelve-month return on equity of 11.97%.

Shares of BVNRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/21/2026
Today
9/22/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:BVNRY
CIK
N/A
Employees
1,692
Year Founded
1994

Profitability

EPS (Trailing Twelve Months)
$0.99
Trailing P/E Ratio
10.80
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$208.23 million
Net Margins
24.36%
Pretax Margin
30.86%
Return on Equity
11.97%
Return on Assets
10.55%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.53
Quick Ratio
3.91

Sales & Book Value

Annual Sales
$945.43 million
Price / Sales
2.69
Cash Flow
$1.36 per share
Price / Cash Flow
7.88
Book Value
$8.20 per share
Price / Book
1.30

Miscellaneous

Outstanding Shares
237,800,000
Free Float
N/A
Market Cap
$2.54 billion
Optionable
Not Optionable
Beta
1.20

Social Links

10 Best Stocks to Own - Fall 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (OTCMKTS:BVNRY) was last updated on 9/22/2026 by MarketBeat.com Staff.
From Our Partners